MR

Mike Ross

Managing Partner at SV Life Sciences

San Mateo, California

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Education

Lists including Mike

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Eyebiotech

Seed

Total Funding: $130M

Therini Bio

Seed

Total Funding: $62M

Xilio Therapeutics

Series A

Total Funding: $330M

Thesan Pharmaceuticals

Series B

Total Funding: $65M

Avitide

Series A

Total Funding: $21M

Arsanis

Series A

Total Funding: $76M

Archemix

Series A

Total Funding: $100M

Work Experience

SH
SV Health Investors

2001

  • Senior Partner

    2001

MetaXen

1993 - 1996

  • CEO

    1993 - 1996

Arris Pharmaceutical

1990 - 1993

  • CEO

    1990 - 1993

G
Genentech

1978 - 1990

  • VP Medicinal and Biomolecular Chemistry

    1987 - 1990

  • VP Development

    1981 - 1987

  • Director Protein Chemistry

    1979 - 1981

  • Sr Scientist

    1978 - 1979